an internationally leading provider of RNA technology products, including RNA isolation and mRNA amplification kits, synthetic long RNAs and DNAs as well as functional mRNAs.
We are committed to direct and flexible customer interactions with life science industries and academic research institutions around the world, including on-site technical support.
AmpTec CEOs Dr. Peter Scheinert and Dr. Guido Krupp
Our products meet the requirements of the finest international standards:
CMC Pharma GmbH and AmpTec GmbH close consulting agreement for API-mRNA production according to GMP FDA 21 CFR Part 210, 211, ICH Q7 for IND/CTA use in early phase clinical studies.Download PDF
AmpTec Expands Scope for its quality management system, certified by DQS MED:
New Scope: production and sales of synthetic nucleic acids for diagnostic AND therapeutic use.
This solution consists of Class D-C-B-A (EU-GMP-Annex1) or Class 100.000-100 (FDA Aseptic Guide) and is determined for Aseptic Fill & Finish of our mRNAs.
Joint expertise to provide custom services for in vitro transcribed (IVT) single-
stranded (ss) and double-stranded (ds) RNAs and for functional synthetic mRNAs.
Ebersberg, Germany, July 1st, 2014 - Eurofins Genomics, international market leader in genomic services, and AmpTec, internationally recognized provider of RNA technology products, have agreed on non-exclusively co-marketing AmpTec's IVT-RNAs globally...
February 2013 - Hamburg-based supplier AmpTec and US diagnostic company Insight Genetics
sign exclusive supply contract for synthetic reference RNAs.
This press release is available in German only.